Evidence map›Paper›PMID 35682933›Full record

ArticleInternational journal of molecular sciences2022

SARS-CoV-2 Continuous Genetic Divergence and Changes in Multiplex RT-PCR Detection Pattern on Positive Retesting Median 150 Days after Initial Infection.

Dakai Liu, George D Rodriguez, Hang-Yu Zhou, Ye-Xiao Cheng, Xiaofeng Li, Wenwen Tang, Nishant Prasad, Chun-Cheng Chen, Vishnu Singh, Eric Konadu and 6 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Dakai LiuDepartment of Pathology and Clinical Laboratories, NewYork-Presbyterian Queens, 56-45 Main Street Flushing, New York, NY 11355, USA.ORCID 0000-0003-0658-5866
George D RodriguezDivision of Infectious Disease, NewYork-Presbyterian Queens, 56-45 Main Street Flushing, New York, NY 11355, USA.
Hang-Yu ZhouInstitute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China.ORCID 0000-0002-3762-2319
Ye-Xiao ChengInstitute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China.
Xiaofeng LiNational Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangzhou 510182, China.
Wenwen TangVascular Biology and Therapeutics Program, Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA.
Nishant PrasadDivision of Infectious Disease, NewYork-Presbyterian Queens, 56-45 Main Street Flushing, New York, NY 11355, USA.
Chun-Cheng ChenDepartment of Surgery, NewYork-Presbyterian Queens, 56-45 Main Street Flushing, New York, NY 11355, USA.
Vishnu SinghDepartment of Pathology and Clinical Laboratories, NewYork-Presbyterian Queens, 56-45 Main Street Flushing, New York, NY 11355, USA.
Eric KonaduDepartment of Pathology and Clinical Laboratories, NewYork-Presbyterian Queens, 56-45 Main Street Flushing, New York, NY 11355, USA.
Keither K JamesDepartment of Pathology and Clinical Laboratories, NewYork-Presbyterian Queens, 56-45 Main Street Flushing, New York, NY 11355, USA.
Maria F BahamonDepartment of Pathology and Clinical Laboratories, NewYork-Presbyterian Queens, 56-45 Main Street Flushing, New York, NY 11355, USA.
Yvonne ChenDepartment of Pathology and Clinical Laboratories, NewYork-Presbyterian Queens, 56-45 Main Street Flushing, New York, NY 11355, USA.
Sorana Segal-MaurerDivision of Infectious Disease, NewYork-Presbyterian Queens, 56-45 Main Street Flushing, New York, NY 11355, USA.
Aiping WuInstitute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China.ORCID 0000-0002-5869-651X
William Harry RodgersDepartment of Pathology and Clinical Laboratories, NewYork-Presbyterian Queens, 56-45 Main Street Flushing, New York, NY 11355, USA.
New York Hospital Queens · USChinese Academy of Medical Sciences & Peking Union Medical College · CNCornell University · USState Key Laboratory of Respiratory Disease · CNYale University · US

Funding

the CAMS Innovation Fund for Medical Sciences 2021-I2M-1-061the National key research and development program 2021YFC2301300the National Natural Science Foundation of China 92169106
6 · The paper itself

Abstract

Being in the epicenter of the COVID-19 pandemic, our lab tested 193,054 specimens for SARS-CoV-2 RNA by diagnostic multiplex reverse transcription polymerase chain reaction (mRT-PCR) starting in March 2020, of which 17,196 specimens resulted positive. To investigate the dynamics of virus molecular evolution and epidemiology, whole genome amplification (WGA) and Next Generation Sequencing (NGS) were performed on 9516 isolates. 7586 isolates with a high quality were further analyzed for the mutation frequency and spectrum. Lastly, we evaluated the utility of the mRT-PCR detection pattern among 26 reinfected patients with repeat positive testing three months after testing negative from the initial infection. Our results show a continuation of the genetic divergence in viral genomes. Furthermore, our results indicate that independent mutations in the primer and probe regions of the nucleocapsid gene amplicon and envelope gene amplicon accumulate over time. Some of these mutations correlate with the changes of detection pattern of viral targets of mRT-PCR. Our data highlight the significance of a continuous genetic divergence on a gene amplification-based assay, the value of the mRT-PCR detection pattern for complementing the clinical diagnosis of reinfection, and the potential for WGA and NGS to identify mutation hotspots throughout the entire viral genome to optimize the design of the PCR-based gene amplification assay.

Indexed as

COVID-19SARS-CoV-2Clinical Laboratory TechniquesCOVID-19 TestingHumansMultiplex Polymerase Chain ReactionPandemicsReverse Transcriptase Polymerase Chain ReactionRNA, ViralSensitivity and SpecificityRNA, ViralCOVID-19genetic divergencemultiplex RT-PCRmutationnext generation sequencingSARS-CoV-2viral variants

Identifiers

PMID35682933
PMCPMC9181733
OpenAlexW4281670356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.